BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
3.190
+0.100 (3.24%)
At close: May 13, 2025, 4:00 PM
3.151
-0.039 (-1.24%)
After-hours: May 13, 2025, 6:48 PM EDT
BioLineRx Stock Forecast
BLRX's stock price has decreased by -87.77% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for BioLineRx stock has a target of 26, which predicts a 715.05% increase from the current stock price of 3.19.
Price Target: $26.00 (+715.05%)
Analyst Consensus: Buy
* Price targets were last updated on Mar 31, 2025.
Analyst Ratings
The average analyst rating for BioLineRx stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $26 | Strong Buy | Maintains | $9 → $26 | +715.05% | Mar 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $840 → $360 | Strong Buy | Maintains | $840 → $360 | +11,185.27% | Nov 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $840 | Strong Buy | Reiterates | $840 | +26,232.29% | Nov 6, 2024 |
| Jones Trading | Jones Trading | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +2,407.84% | Sep 4, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.